Edition:
United States

CorMedix Inc (CRMD.A)

CRMD.A on American Stock Exchange

1.74USD
17 Jan 2017
Change (% chg)

$-0.06 (-3.33%)
Prev Close
$1.80
Open
$1.79
Day's High
$1.79
Day's Low
$1.68
Volume
6,427
Avg. Vol
43,065
52-wk High
$4.53
52-wk Low
$1.17

CRMD.A

Chart for CRMD.A

About

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate,... (more)

Overall

Beta: 0.68
Market Cap(Mil.): $72.77
Shares Outstanding(Mil.): 40.43
Dividend: --
Yield (%): --

Financials

  CRMD.A Industry Sector
P/E (TTM): -- 29.84 30.76
EPS (TTM): -0.60 -- --
ROI: -73.42 15.39 14.82
ROE: -73.49 16.58 16.24

BRIEF-Cormedix reports qtrly earnings per share of $0.23

* Q4 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S Source text for Eikon: [ID:http://bit.ly/2eWMBoS] Further company coverage:

Nov 10 2016

BRIEF-Cormedix Q2 loss per share $0.13

* Qtrly revenue $16,511 versus $119,973 Source text for Eikon: Further company coverage:

Aug 05 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $114.87 +0.27
Pfizer Inc. (PFE.N) $32.06 -0.46
Merck & Co., Inc. (MRK.N) $61.48 -0.86
Abbott Laboratories (ABT.N) $40.90 -0.03
Sanofi SA (SASY.PA) €76.12 -0.69
Eli Lilly and Co (LLY.N) $76.85 -0.55

Earnings vs. Estimates